中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2014年
2期
101-102
,共2页
不稳定型心绞痛%常规治疗%中药%冠心病1号方
不穩定型心絞痛%常規治療%中藥%冠心病1號方
불은정형심교통%상규치료%중약%관심병1호방
Unstable Unstable angina%Routine drug treatment%Traditional Chinese medicine%Coronary heart disease No.1
目的：探讨冠心病1号方治疗不稳定型心绞痛的临床疗效。方法：选取2010年1月-2012年12月笔者治疗的不稳定型心绞痛患者80例，随机分为观察组和对照组，每组40例。对照组给予常规药物治疗如硝酸酯类、低分子肝素，肠溶阿司匹林、波立维（氯吡格雷）、血管紧张素转换酶抑制剂（ACEI）、β受体阻滞剂等；观察组在常规药物治疗的基础上给予冠心病1号方，连用4周。观察比较两组的临床疗效和不良事件发生情况。结果：观察组治疗后总有效率为95.0%，对照组为70.0%，两组比较差异有统计学意义（P<0.05）。两组不良事件发生率比较差异无统计学意义（P>0.05）。结论：在常规药物治疗的基础上使用冠心病1号方治疗不稳定型心绞痛临床疗效显著，且安全可靠，值得临床推广。
目的：探討冠心病1號方治療不穩定型心絞痛的臨床療效。方法：選取2010年1月-2012年12月筆者治療的不穩定型心絞痛患者80例，隨機分為觀察組和對照組，每組40例。對照組給予常規藥物治療如硝痠酯類、低分子肝素，腸溶阿司匹林、波立維（氯吡格雷）、血管緊張素轉換酶抑製劑（ACEI）、β受體阻滯劑等；觀察組在常規藥物治療的基礎上給予冠心病1號方，連用4週。觀察比較兩組的臨床療效和不良事件髮生情況。結果：觀察組治療後總有效率為95.0%，對照組為70.0%，兩組比較差異有統計學意義（P<0.05）。兩組不良事件髮生率比較差異無統計學意義（P>0.05）。結論：在常規藥物治療的基礎上使用冠心病1號方治療不穩定型心絞痛臨床療效顯著，且安全可靠，值得臨床推廣。
목적：탐토관심병1호방치료불은정형심교통적림상료효。방법：선취2010년1월-2012년12월필자치료적불은정형심교통환자80례，수궤분위관찰조화대조조，매조40례。대조조급여상규약물치료여초산지류、저분자간소，장용아사필림、파립유（록필격뢰）、혈관긴장소전환매억제제（ACEI）、β수체조체제등；관찰조재상규약물치료적기출상급여관심병1호방，련용4주。관찰비교량조적림상료효화불량사건발생정황。결과：관찰조치료후총유효솔위95.0%，대조조위70.0%，량조비교차이유통계학의의（P<0.05）。량조불량사건발생솔비교차이무통계학의의（P>0.05）。결론：재상규약물치료적기출상사용관심병1호방치료불은정형심교통림상료효현저，차안전가고，치득림상추엄。
Objective:To explore the clinical efficacy of coronary heart disease No.1 decoction in the treatment of unstable angina pectoris. Method:Eighty cases of patients with unstable type were selected from January 2010 to December 2012 in the treatment of angina pectoris,who were randomly divided into the observation group and the control group,each group of 40 cases. The control group was given routine drug treatment such as nitrate,low molecular weight heparin,aspirin,clopidogrel(Plavix),angiotensin converting enzyme inhibitors(ACEI),beta blockers. In the basic of conventional therapy,the observation group was given coronary heart disease 1 decoction for 4 weeks. The occurrence of adverse events and the clinical curative effects were observed and compared between the two groups after treatment. Result:The effective rate of the control group was 70.0%while the observation group was 95.0%after treatment,and the difference between the two groups were statistically significant(P<0.05). The incidence of adverse events between the two groups were no significantly different(P>0.05). Conclusion:The clinical curative effect of coronary heart disease No.1 drug based on the routine method in treatment of unstable angina pectoris is remarkable,safe and reliable,which is worthy of clinical application.
